Comments

Alnylam Pharmaceuticals Stock Price, Quotes and Forecasts

Q: What sector and industry does Alnylam Pharmaceuticals (ALNY) operate in?

Alnylam Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

ALNYNASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

$283.40

At close: May 15 EDT

$283.40

0.000.00%

Pre-Market: 4:05 PM EDT

Alnylam Pharmaceuticals (ALNY) Forecast

News Earnings Alnylam Pharmaceuticals (ALNY) Options Guidance Dividends Analyst Ratings Insider Trades Government Trades Short Interest

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Alnylam Pharmaceuticals Stock Price, Quotes and Forecasts | NASDAQ:ALNY | Benzinga

Explore Alnylam Pharmaceuticals stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for ALNY.

Open	-
Close	-
Volume / Avg.	6.00 / 988.61K
Day Range	- - -
52 Wk Range	144.73 - 304.39
Market Cap	$36.68B
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	67
Short Interest	3.22%
Days to Cover	4

Recent News

Alnylam Delivers Q1 Surprise, Analysts Highlight Amvuttra Momentum, Limited Tariff Risk

Alnylam analysts highlight Amvuttra's strong launch positioning and limited tariff risk, with bullish ratings maintained despite early launch volatility.

Vandana Singh

Apple To Rally More Than 17%? Here Are 10 Top Analyst Forecasts For Friday

Avi Kapoor

Vertex, Alnylam Best Positioned As Biopharma Braces For Tariff Impact, Goldman Sachs Flags Regeneron, Biogen Risks

Trump's new tariff move may raise U.S. pharma costs, with analysts warning of risks tied to EU manufacturing and shifting healthcare policies.

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Feb

Mar

Apr

May

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.5

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	-
Close	-
Volume / Avg.	6.00 / 988.61K
Day Range	- - -
52 Wk Range	144.73 - 304.39
Market Cap	$36.68B
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	67
Short Interest	3.22%
Days to Cover	4

About Alnylam Pharmaceuticals Inc

Sector

Health Care

Industry

Biotechnology

Alnylam Pharmaceuticals is a leader in the study of RNA interference (RNAi) therapeutics. RNAi is a ...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Alnylam Pharmaceuticals (ALNY) stock?

You can purchase shares of Alnylam Pharmaceuticals (NASDAQ:ALNY) through any online brokerage.

View our list of the best stock brokerages

Who are Alnylam Pharmaceuticals (ALNY) competitors?

Other companies in Alnylam Pharmaceuticals’s space includes: BeiGene (NASDAQ:ONC), Exact Sciences (NASDAQ:EXAS), Neurocrine Biosciences (NASDAQ:NBIX), Roivant Sciences (NASDAQ:ROIV) and Amgen (NASDAQ:AMGN).

What is the forecast, or price target, for Alnylam Pharmaceuticals (ALNY) stock?

Alnylam Pharmaceuticals has a consensus price target of $317.04.

What is the current price for Alnylam Pharmaceuticals (ALNY)?

The stock price for Alnylam Pharmaceuticals (NASDAQ: ALNY) is $283.4 last updated May 15, 2025 at 4:05 PM EDT.

Does Alnylam Pharmaceuticals (ALNY) pay a dividend?

There are no upcoming dividends for Alnylam Pharmaceuticals.

When is Alnylam Pharmaceuticals (NASDAQ:ALNY) reporting earnings?

Alnylam Pharmaceuticals’s Q2 earnings are confirmed for Thursday, July 31, 2025.

Is Alnylam Pharmaceuticals (ALNY) going to split?

There is no upcoming split for Alnylam Pharmaceuticals.

What sector and industry does Alnylam Pharmaceuticals (ALNY) operate in?

Alnylam Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.